Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Dermatologic

Jan. 1, 2022

TOPADUR Pharma identifies dual PDE5A inhibitors/soluble guanylate cyclase activators

Dec. 29, 2021

Researchers publish preclinical data on dimeric peptides as hair growth stimulants for alopecia

Dec. 27, 2021

Pfizer synthesizes new JAK1 inhibitors

Dec. 17, 2021

Concert Pharmaceuticals presents new JAK inhibitors

Dec. 15, 2021

Ichnos grants Almirall global rights to develop and commercialize ISB-880 for autoimmune diseases

Dec. 14, 2021

New Wnt signaling activators identified at Biosplice Therapeutics

Dec. 9, 2021

BCL10/MALT1 axis found to be involved in psoriasis

Dec. 3, 2021

Targeting TWEAK shows potential as alternative therapeutic strategy for psoriasis

Dec. 2, 2021

New RIPK1 inhibitors presented by National Institute of Pharmaceutical R&D

Nov. 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...